Company Filing History:
Years Active: 2012-2013
Title: Innovations in Cancer Treatment by Jin-Wook Lee
Introduction
Jin-Wook Lee is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 2 patents, his work focuses on the use of inhibitors targeting the leukotriene B4 receptor BLT2 for treating various human cancers.
Latest Patents
Jin-Wook Lee's latest patents include a method of treating cancer with antibodies against the long-form leukotriene B4 receptor BLT2. This invention relates to the use of BLT2 inhibitors in pharmaceutical compositions aimed at treating human cancers. The research highlights the role of BLT2 as a survival factor in cancers such as bladder, prostate, pancreatic, and breast cancer. Furthermore, the inventors have demonstrated that BLT2 inhibitors can serve as effective anti-cancer drugs by inducing apoptosis in cancer cells, inhibiting metastasis, and preventing tumor angiogenesis.
Career Highlights
Jin-Wook Lee is affiliated with the Korea University Research and Business Foundation, where he continues to advance his research in cancer therapies. His work has garnered attention for its potential to improve treatment outcomes for patients suffering from various types of cancer.
Collaborations
Jin-Wook Lee has collaborated with notable researchers, including Jae-Hong Kim and Jung-A Choi, to further explore the applications of BLT2 inhibitors in cancer treatment.
Conclusion
Jin-Wook Lee's innovative research and patents represent a significant advancement in the fight against cancer. His work not only contributes to scientific knowledge but also holds promise for developing new therapeutic strategies for patients.